Rupal Sinha
Banaras Hindu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rupal Sinha.
Asian Pacific Journal of Cancer Prevention | 2015
Dinesh Chandra Doval; Anila Sharma; Rupal Sinha; Kapil Kumar; Ajay Kumar Dewan; Harit Chaturvedi; Ullas Batra; Vineet Talwar; Sunil Kumar Gupta; Shailendra Singh; Vidula Bhole; Anurag Mehta
BACKGROUND To assess the immunohistochemical expression of estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor-2 (HER2) neu receptor in breast cancer and their associations with various clinicopathological characteristics. MATERIALS AND METHODS This is a retrospective analysis of women who presented with primary, unilateral breast cancer in the Department of Medical Oncology at Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India during the period from January 2008 to December 2011. Data were retrieved from the medical records of the hospital including both early and locally advanced cancer cases. ER, PgR and HER2neu expression in these patients was assessed and triple negative patients were identified. Associations of triple negative and non-triple negative groups with clinicopathological characteristics were also evaluated. RESULTS A total of 1,284 women (mean age 52.1 years, 41.9% premenopausal) were included in the analysis. Hormone receptor positivity (ER and/or PgR) was seen in 63.4% patients, while 23.8% of tumors were triple negative. Only 23.0% were HER2 positive. Around 10.0% of tumors were both ER and HER2 positive. ER and PgR positivity was significantly associated with negative HER2 status (p-value<0.0001). Younger age, premenopausal status, higher tumor grade, lymph node negativity, advanced cancer stage, and type of tumor were strongly associated with triple negativity. Significantly, a smaller proportion of women had ductal carcinoma in situ in the triple negative group compared with the non-triple negative group (35.6% versus 60.8%, p-value<0.01). CONCLUSIONS The present analysis is one of the largest studies from India. The majority of the Indian breast cancer patients seen in our hospital present with ER and PgR positive tumors. The triple negative patients tended to be younger, premenopausal, and were associated with higher tumor grades, negative lymph nodes status and lower frequency of ductal carcinoma in situ.
Asian Pacific Journal of Cancer Prevention | 2015
Rupal Sinha; Dinesh Chandra Doval; Showket Hussain; Kapil Kumar; Shivendra Singh; Seemi Farhat Basir; Mausumi Bharadwaj
BACKGROUND The study evaluated the patient, lifestyle and tumor profile in patients undergoing upfront surgery for sporadic colorectal cancer (CRC) in Indian population. MATERIALS AND METHODS One hundred consecutive patients were included. Details related to their demographic profile, habits, signs and symptoms, tumor profile, further treatment and follow up were recorded. RESULTS The majority of the patients had colonic cancer (68%), advanced tumor stage 3 and 4 (46%), moderately differentiated tumors (70%) with absence of lymphatic invasion (60%) and metastasis (90%). Correlations between tumor location and abdominal pain (p-value 0.002), bleeding per rectum (p-value <0.001), difficulty in micturition (p-value 0.012) and constipation (p-value 0.007) were found to be statistically significant. Abdominal pain was more frequently reported in patients with metastasis (p-value 0.031). Loss of weight statistically correlated with absence of lymphatic invasion (p-value 0.047). Associations between tumor stage and alcohol intake (p-value 0.050) and non vegetarian diet (p-value 0.006); lymphatic invasion and intake of spicy food (p-value 0.040) and non vegetarian diet (p-value 0.001) and metastasis and alcohol intake (p-value 0.041) were also observed. Age and tumor grade were also correlated (p-value 0.020). CONCLUSIONS Minimizing the adverse lifestyle factors can help in reducing the overall incidence of CRC in the Indian population.
Indian Journal of Medical and Paediatric Oncology | 2017
DineshChandra Doval; Dinesh Bhurani; Reena Nair; Sumeet Gujral; Pankaj Malhotra; Ganpati Ramanan; Ravi Mohan; Ghanshyam Biswas; Satya Dattatreya; Shyam Agarwal; Dinesh Pendharkar; PramodKumar Julka; SureshH Advani; RupinderSingh Dhaliwal; Juhi Tayal; Rupal Sinha; Tanvir Kaur; GouraK Rath
This consensus document is based on the guidelines related to the management of Non Hodgkins Lymphoma (High grade) in the Indian population as proposed by the core expert committee. Accurate diagnosis in hematolymphoid neoplasm requires a combination of detailed history,clinical examination, and various investigations including routine laboratory tests, good quality histology section (of tumor and also bone marrow aspirate/biopsy), immunostaining, cytogenetic and molecular studies and radiology investigations. The staging system used for adult high grade lymphomas is based on the Ann Arbor system and includes various parameters like clinical, haematology, biochemistry, serology and radiology. Response should be evaluated with radiological evaluation after 3-4 cycles and at the end of treatment based on criteria including and excluding PET. Treatment of high grade lymphomas is based on histologic subtype, extent of disease, and age of the patient. Autologous stem cell transplantation after high dose chemotherapy is effective in the treatment of relapsed NHL. Newer RT techniques like 3 dimensional conformal radiation therapy (3D-CRT) and intensity modulated radiation therapy (IMRT) can significantly reduce radiation doses to surrounding normal tissues in lymphoma patients. Patients should be followed up every 3 to 4 months for the first 2 years, followed by 6 monthly for the next 3 years and then annually.
Current Developments in Biotechnology and Bioengineering#R##N#Crop Modification, Nutrition, and Food Production | 2017
Jainendra Pathak; Rajneesh; Abha Pandey; Shailendra P. Singh; Rupal Sinha
Abstract Global agriculture is facing a serious threat from climate change, which may result in reduced productivity. Increasing food prices and greater global food insecurity are the outcomes of decreased productivity, and the persistence of such conditions may lead to a further increase in food prices, which could lead to social unrest and famine in certain instances. To ensure continued food security for an increasing global population, we must focus on improving crop productivity by exploiting new genetic sequencing and advanced “genomic breeding” and proteomics technologies. These technologies hold promise for crop improvement by developing crop species for particular environmental conditions. These technologies also allow plant breeders to target new crop species and traits effectively and simultaneously, such as resilience, quality, and yield, which are crucial to food security. Molecular breeding has a crucial role in improving crops. Although genetically modified (GM) crops hold good promise in enhancing crop productivity, GM crops face several challenges in agricultural growth, development, and sustainability. In this chapter, we discuss advances in the field of agriculture using advanced tools of biotechnology.
Perspectives in Clinical Research | 2015
Dinesh Chandra Doval; Rashmi Shirali; Rupal Sinha
Clinical trials are the mainstay for bringing out newer and better drugs to serve the mankind. By virtue of participating in a clinical trial, a patient receives access to the newer drugs/therapies, but nothing is generally being offered to them once their participation in the study comes to an end. Though the issue of post-trial access to treatment by patients participating in a clinical trial is debatable, there is no compelling justification either for or against it. We examined a case study in order to evaluate the applicability of post-trial access to treatment for patients participating in clinical trials. The provision of post-trial access to treatment should also keep into consideration the compassionate use of drugs on humanitarian grounds, especially in cases of trial drugs that have offered significant benefit to the trial patients and whose termination would lead to deterioration in patients overall condition. In the present era of personalized medicine, the incorporation of genetic testing into clinical practice further authenticates the rationale of compassionate use of drugs and post-trial access to treatment.
Journal of Gastrointestinal Cancer | 2015
Dinesh Chandra Doval; Saud Azam; Rupal Sinha; Ullas Batra; Anurag Mehta; Avinash Rao
Gallbladder carcinoma (GBC) is a rare disease around most parts of the world but is common in the northern part of India, Japan, and Chile [1]. It is a very aggressive tumor which is diagnosed in the advanced stages and has very poor prognosis. The most common site of metastasis at the time of first diagnosis is the liver [2]. Least common sites of metastasis are lung, cerebral, and osseous [3]. Leptomeningeal carcinomatosis (LMC) is among the most serious complications in cancer, and in GBC, it is rarely reported. We report two cases of GBC with LMC during the treatment without metastasis in the central nervous system (CNS).
Japanese Journal of Clinical Oncology | 2014
Ajay Kumar Dewan; Surender Dabas; Tapaswini Pradhan; Sandeep Mehta; Abhinav Dewan; Rupal Sinha
OBJECTIVE The report presents an 11-year Institutional experience of 203 cases with superior gingivobuccal sulcus tumours receiving surgical intervention at a comprehensive tertiary cancer care centre. METHODS A retrospective chart review of patients with a confirmed diagnosis of squamous cell carcinoma of superior gingivobuccal sulcus was done and data related to patient demographic profile; details of surgical procedure, follow-up and survival were collected. RESULTS Infratemporal fossa clearance was performed in 56 patients. The 10-year overall survival and disease-free survival was observed to be 39 and 52%, respectively, with a median follow-up of 15 months. The overall survival was 40 and 36%, respectively, in cases with and without infratemporal fossa clearance. Similarly, the disease-free survival was found to be 58 and 49%, respectively, in cases with and without infratemporal fossa clearance. CONCLUSION Patients with higher stage tumours who underwent infratemporal fossa clearance showed better overall and disease-free survival than those who did not undergo infratemporal fossa clearance.
Archive | 2008
Sunita Kumari; Rajesh P. Rastogi; Kanchan Singh; Shailendra P. Singh; Rajeshwar P. Sinha; Rupal Sinha
Journal of Gastrointestinal Cancer | 2015
Meenakshi Kamboj; Jatin S Gandhi; Gurudutt Gupta; Anila Sharma; Sunil Pasricha; Anurag Mehta; D. Chandragouda; Rupal Sinha
International Journal of Clinical Oncology | 2015
Surender Dabas; Abhinav Dewan; Reetesh Ranjan; Ajay Kumar Dewan; Anoop Puri; Swati H. Shah; Rupal Sinha